AstraZeneca Boosts Cancer Portfolio With $320 Million Neogene Deal ...Middle East

Medscape - News
AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, seeking to build its pipeline of cell-based cancer treatments. Reuters Health Information

Hence then, the article about astrazeneca boosts cancer portfolio with 320 million neogene deal was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca Boosts Cancer Portfolio With $320 Million Neogene Deal )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News